Spontaneous Tumor Lysis Syndrome in Refractory Metastatic Esophageal Adenocarcinoma Presenting With Septic Shock

Spontaneous tumor lysis syndrome (STLS) presents a diagnostic challenge when it occurs in patients with advanced solid malignancies and concurrent critical illness.We present a case of STLS in a 30-year-old man with refractory metastatic esophageal adenocarcinoma who presented with hypotension, anuria, and severe metabolic derangements.Laboratory evaluation demonstrated hyperuricemia (18.1 mg/dL), hyperkalemia (7.6 mmol/L), hyperphosphatemia (7.8 mg/dL), and acute kidney injury.Ionized calcium was also low at 1.03 mmol/L despite hypoalbuminemia, with laboratory and clinical findings consistent with TLS by Cairo-Bishop thresholds.His final treatment was initiated 19 days before presentation, with the continuous fluorouracil infusion completed approximately 17 days before presentation, placing the presentation well outside the conventional treatment-related timeframe.His course was complicated by septic shock secondary to methicillin-sensitive Staphylococcus aureus bacteremia.Despite supportive care and rasburicase administration, he developed multiorgan failure and was transitioned to hospice.This case highlights the rare occurrence of spontaneous TLS in metastatic esophageal adenocarcinoma and emphasizes the importance of early recognition and consideration in any patient with high tumor burden.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-09-08
DOI
https://doi.org/10.7759/cureus.115957
Primary Topic
Methemoglobinemia and Tumor Lysis Syndrome
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Spontaneous Tumor Lysis Syndrome in Refractory Metastatic Esophageal Adenocarcinoma Presenting With Septic Shock

Marlee Thomas, Abigail Orenstein, Kevin T Jamouss, Andrew T Ng
Cureus
Methemoglobinemia and Tumor Lysis Syndrome
article

Spontaneous Tumor Lysis Syndrome in Refractory Metastatic Esophageal Adenocarcinoma Presenting With Septic Shock

Marlee Thomas, Abigail Orenstein, Kevin T Jamouss, Andrew T Ng
article en

Abstract

Spontaneous tumor lysis syndrome (STLS) presents a diagnostic challenge when it occurs in patients with advanced solid malignancies and concurrent critical illness.We present a case of STLS in a 30-year-old man with refractory metastatic esophageal adenocarcinoma who presented with hypotension, anuria, and severe metabolic derangements.Laboratory evaluation demonstrated hyperuricemia (18.1 mg/dL), hyperkalemia (7.6 mmol/L), hyperphosphatemia (7.8 mg/dL), and acute kidney injury.Ionized calcium was also low at 1.03 mmol/L despite hypoalbuminemia, with laboratory and clinical findings consistent with TLS by Cairo-Bishop thresholds.His final treatment was initiated 19 days before presentation, with the continuous fluorouracil infusion completed approximately 17 days before presentation, placing the presentation well outside the conventional treatment-related timeframe.His course was complicated by septic shock secondary to methicillin-sensitive Staphylococcus aureus bacteremia.Despite supportive care and rasburicase administration, he developed multiorgan failure and was transitioned to hospice.This case highlights the rare occurrence of spontaneous TLS in metastatic esophageal adenocarcinoma and emphasizes the importance of early recognition and consideration in any patient with high tumor burden.

Cureus
Baystate Medical Center (US), Baystate Health (US)
Good health and well-being
Openalex Percentile: Top 12%
Methemoglobinemia and Tumor Lysis Syndrome
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.